GlaxoSmithKline PLC
21 April 2005
GLAXOSMITHKLINE plc - Notification of Major Interests in Shares
GlaxoSmithKline plc (the Company) yesterday received notification from Barclays
plc in compliance with Part VI of the Companies Act 1985 (as amended), that on
14 April 2005 it had the following interests in the Company's Ordinary Shares of
25 pence:
Registered Holder Current shareholding
Barclays Global Fund Advisors 13,253,089
Barclays Life Assurance Co Ltd 8,626,453
Barclays Private Bank and Trust Ltd 1,000
Barclays Private Bank and Trust Ltd 267,671
Barclays Global Investors Ltd 101,445,177
Barclays Capital Securities Ltd 28,289,611
Gerrard Ltd 1,975,464
Barclays Ban Trust Company Ltd 937,538
Barclays Capital Inc 1,066,000
Barclays Global Investors Japan Ltd 4,602,669
Barclays Private Bank Ltd 1,785,032
Barclays Global Investors Australia Ltd 2,207,508
Barclays Global Investors Japan Trust & Banking 7,439,862
Barclays Global Investors, N.A. 70,693,867
Barclays Private Bank & Trust Ltd 11,495
TOTAL 242,602,436
Barclays plc's total holding has increased from 3.91 per cent to 4.14 per cent
of the issued share capital of the Company (excluding shares held in Treasury).
S M Bicknell
Company Secretary
21 April 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.